ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 194 filers reported holding ACORDA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -75.0% | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | -100.0% | 500 | -99.9% | 0.00% | -100.0% |
| Q1 2019 | $10,460,000 | -14.4% | 787,035 | +0.4% | 0.01% | -25.0% |
| Q4 2018 | $12,219,000 | -20.4% | 784,271 | +0.3% | 0.01% | -7.7% |
| Q3 2018 | $15,358,000 | -31.5% | 781,591 | +0.0% | 0.01% | -27.8% |
| Q2 2018 | $22,430,000 | +21.9% | 781,522 | +0.5% | 0.02% | +5.9% |
| Q1 2018 | $18,394,000 | -9.7% | 777,749 | -18.1% | 0.02% | -10.5% |
| Q4 2017 | $20,367,000 | -9.3% | 949,518 | +0.0% | 0.02% | -13.6% |
| Q3 2017 | $22,450,000 | +20.1% | 949,265 | +0.0% | 0.02% | +22.2% |
| Q2 2017 | $18,694,000 | -5.8% | 948,927 | +0.4% | 0.02% | -10.0% |
| Q1 2017 | $19,852,000 | +11.9% | 945,338 | +0.2% | 0.02% | 0.0% |
| Q4 2016 | $17,743,000 | -10.1% | 943,790 | -0.1% | 0.02% | -9.1% |
| Q3 2016 | $19,731,000 | -18.1% | 944,981 | +0.0% | 0.02% | -21.4% |
| Q2 2016 | $24,097,000 | -3.2% | 944,807 | +0.4% | 0.03% | -6.7% |
| Q1 2016 | $24,885,000 | -39.0% | 940,847 | -1.4% | 0.03% | -36.2% |
| Q4 2015 | $40,826,000 | +60.8% | 954,321 | -0.4% | 0.05% | +56.7% |
| Q3 2015 | $25,389,000 | -23.3% | 957,721 | -3.5% | 0.03% | -14.3% |
| Q2 2015 | $33,094,000 | -0.7% | 992,931 | -0.9% | 0.04% | 0.0% |
| Q1 2015 | $33,335,000 | -18.4% | 1,001,654 | +0.2% | 0.04% | -18.6% |
| Q4 2014 | $40,871,000 | +19.7% | 1,000,023 | -0.7% | 0.04% | +13.2% |
| Q3 2014 | $34,132,000 | +1.1% | 1,007,432 | +0.6% | 0.04% | 0.0% |
| Q2 2014 | $33,749,000 | -10.8% | 1,001,147 | +0.3% | 0.04% | -15.6% |
| Q1 2014 | $37,827,000 | +37.4% | 997,820 | +5.8% | 0.04% | +32.4% |
| Q4 2013 | $27,530,000 | -3.6% | 942,823 | +12.9% | 0.03% | -15.0% |
| Q3 2013 | $28,568,000 | +40.9% | 835,320 | +35.9% | 0.04% | +29.0% |
| Q2 2013 | $20,276,000 | – | 614,588 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |